Advertisement
Screener

NURIX THERAPEUTICS, INC. (NRIX) ROA

NURIX THERAPEUTICS, INC. (NRIX) ROA

  • 2026-05-31: ROA -63.74%.
  • 2026-02-28: ROA -46.42%.
  • 2025-11-30: ROA -38.43%.
  • 2025-08-31: ROA -46.85%.

Complete source-backed roa history.

Available history
2019-11-30 to 2026-05-31
Data captured

Historical ROA

DateROA
2026-05-31-63.74%
2026-02-28-46.42%
2025-11-30-38.43%
2025-08-31-46.85%
2025-05-31-35.05%
2025-02-28-33.88%
2024-11-30-28.92%
2024-08-31-34.46%
2024-05-31-32.29%
2024-02-29-46.29%
2023-11-30-40.48%
2023-08-31-48.25%
2023-05-31-44.90%
2023-02-28-48.24%
2022-11-30-43.28%
2022-08-31-37.30%
2022-05-31-39.18%
2022-02-28-30.94%
2021-11-30-24.58%
2021-08-31-20.16%
2021-05-31-17.20%
2021-02-28-13.90%
2020-11-30-10.91%
2020-08-31-8.95%
2019-11-30-49.26%

Annual ROA

DateROA
2025-11-30-38.43%
2024-11-30-28.92%
2023-11-30-40.48%
2022-11-30-43.28%
2021-11-30-24.58%
2020-11-30-10.91%
2019-11-30-49.26%

Similar stocks

Stock NameCountryMarket CapPE Ratio
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36